-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $18

Benzinga·10/21/2026 13:51:30
语音播报
TD Cowen analyst Stacy Ku maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and raises the price target from $17 to $18.